Genetic testing of BRCA1/2 has become the standard of care for all women with HGSC, with the primary goal of identifying hereditary cancer families to provide accurate risk assessment, surveillance, and risk reduction options for at‐risk individuals. Here, BRCA1 is linked to cancer.